Venture Capital & Private Equity / Canadian Firms ALBERTA ENTERPRISE CORPORATION Suite 1100 10830 Jasper Avenue Edmonton, AB T5J 2B3 Canada Phone: 780-392-3901 Fax: 780-392-3908 e-mail: [email protected] web: www.alberta-enterprise.ca Mission Statement: To fund and foster new venture capital fund managers in Alberta and to develop and support the startup community to ensure quality deal flow. Geographic Preference: Alberta Fund Size: $100 million Founded: 2008 Industry Group Preference: Software, Internet, Media, Manufacturing, Clean Technology, Energy, Medical Devices, Life Sciences, Pharmaceuticals, Electronics Portfolio Companies: iNovia Capital, Chrysalix Energy Venture Capital, Yaletown Venture Partners Key Executives: Rod Charko, Chief Executive Officer Education: BSc, University of Calgary; MSc, Engineering, University of Washington; MBA, University of Western Ontario Background: Advisor, BDC Venture Capital Rebecca Giffen, Director of Investments Education: BComm, Haskayne School of Business, University of Calgary Background: Director of Fund Investments, BDC Venture Capital Carey Houston, Director of Industry Development Education: BComm, University of Alberta; MBA, Richard Ivey School of Business Kristina Williams, Director of Investments Education: Master of Laws, Uppsala University; MBA, University of Alberta Background: Director of Marketing, Cevena Bioproducts; VP Marketing, Natraceutical Canada ALBERTA INVESTMENT MANAGEMENT CORP. 1100-10830 Jasper Avenue Edmonton, AB T5J 2B3 Canada Phone: 780-392-3600 e-mail: [email protected] web: www.aimco.alberta.ca Mission Statement: Operating on commercial principles with a strong Board, AIMCo is determined to produce superior, long-term investment results without taking unacceptable risks. Our evolution from a division of government to a Crown corporation is critical to good governance and sound investment decisions. That will put us in a better position to meet the evolving needs of our clients, respond to market changes and compete and excel in a competitive global marketplace. Founded: 2008 Portfolio Companies: Axcan Pharma, CCS, Cengage, Ceridian, DGAM, Generac, GLM, KMC, RTL-Westcan Key Executives: Leo De Bever, CEO/Chief Investment Officer Education: BA, Economics, University of Oregon; MA, PhD, University of Wisconsin, Madison Venture Capital & Private Equity / Canadian Firms Mission Statement: To build Canada’s next generation of global business success stories. Geographic Preference: Canada NORTHLEAF CAPITAL PARTNERS 79 Wellington Street West 6th Floor, Box 120 Toronto, ON M5K 1N9 Canada Fax: 416-304-0195 Toll-Free: 866-964-4141 e-mail: [email protected] web: www.northleafcapital.com Mission Statement: Northleaf is a global private markets investor with strong Canadian roots and a long history of superior investment returns. We are committed to building enduring relationships with our investors, fund managers, business partners and colleagues based on trust, respect, and the highest standards of integrity and professionalism. Geographic Preference: North America, Europe, Asia Fund Size: 3.7 billion Investment Criteria: Venture & Growth Equity, Buyouts, Special Situations Other Locations:
14 Waterloo Place 4th Floor London SW1Y 4AR United Kingdom Phone: 44-20-7321-5750 Fax: 44-30-7930-7171
3000 Sand Hill Road Building 1, Suite 230 Menlo Park, CA 94025 Phone: 650-234-9810 Fax: 650-234-9859 Key Executives: David Austin, Managing Director e-mail: [email protected] Education: AB, Harvard University; BA, Law, Master’s in Law & Economics, Oxford University Background: TD Capital Private Equity, BMO Nesbitt Burns Daniel Dupont, Managing Director e-mail: [email protected] Education: BBA, MBA, International Finance, HEC Montreal; CA Background: Coller Capital, National Bank of Canada Michael Flood, Managing Director e-mail: [email protected] Education: BA, Queen’s Univeristy; MS, Indiana University; MBA, Richad Ivey School of Business Background: TD Capital Private Equity, Harrowston, Royal Bank Capital Partners Gavin Foo, Chief Financial Officer e-mail: [email protected] Education: BComm, University of Toronto; CA Background: TD Capital Private Equity; SVP/CFO, IA Clarington Investments; Trimark Financial Corporation; Coopers & Lybrand Melissa McJannet, Managing Director e-mail: [email protected] Education: BA, Queen’s University; MBA, Stanford Graduate School of Business Background: TD Captial Private Equity; Associate, Mayfield; RBC Dominion College/University Index / Amos Tuck School of Business Amos Tuck School of Business Haskayne School of Business Bangalore University Dartmouth College Henley Management College Bishop’s University DeGroote School of Business Hong Kong Polytechnic University Boston College ESADE Business School Hull University Boston University Ecole Polytechnique Montreal Bowdoin College Emory University
Evan McCordick, 40Loudon Mclean Owen, 109
Bowling Green State University Fordham University Indiana University Brandeis University Georgetown University John Carroll University Brown University John Molson School of Business Bucknell University Johns Hopkins University HEC Business School California Institute of Technology Kellogg School of Management HEC Montreal Cambridge University Carleton University Paul Chiarelli, 162 HEC Paris L’Ecole Polytechnique Harvard Business School Lakehead University College of William & Mary Laurential University Columbia Business School Laurentian University Columbia University Laval University Concordia University Lehigh University London School of Business Cornell University Harvard University London School of Economics Dalhousie Law School London University Dalhousie University Loyola College Executive Name Index Geographic Index / Canada
BIOENTERPRISE, 19BIRCH HILL EQUITY PARTNERS, 20
CANADIAN VENTURE CAPITAL ASSOCIATION, 2456
EMERALD TECHNOLOGY VENTURES, 55ENERTECH CAPITAL, 516
MARS CLEANTECH FUND, 101MARS INVESTMENT ACCELERATOR FUND, 102
MEDWELL CAPITAL, 105MERCATOR INVESTMENTS, 106
MONITOR GROUP Monitor Company Canada, 952
NSBI VENTURE CAPITAL Nova Scotia Business Inc., 116
NEWHAVEN CORPORATE FINANCE LIMITED, 111NFQ VENTURES, 113
Industry Preference Index / Advanced Manufacturing Advanced Manufacturing Building Materials & Services
SCOTIABANK PRIVATE EQUITY, 137XPV CAPITAL, 167
Advanced Materials EMERALD TECHNOLOGY VENTURES, 55 Business Services Advanced Technologies
NEWHAVEN CORPORATE FINANCE LIMITED, 111PARKVIEW CAPITAL PARTNERS, 124
Advertising
SCOTIABANK PRIVATE EQUITY, 137SIGNAL HILL EQUITY PARTNERS, 139
Aerospace
NSBI VENTURE CAPITAL Nova Scotia Business Inc., 116
WESTCAP MGT, 163WESTERN AMERICA CAPITAL GROUP, 164
Agricultural Technologies Business to Business Agriculture
FCC VENTURES Farm Credit Canada, 60FORAGEN TECHNOLOGIES MANAGEMENT, 63
Capital Equipment Chemicals TORQUEST PARTNERS, 149 All Sectors Considered CLAIRVEST GROUP, 38 Clean Technology
BC RENAISSANCE CAPITAL FUND, 13BDC VENTURE CAPITAL Business Development Bank of Canada, 14
Alternative Energy
EMERALD TECHNOLOGY VENTURES, 55GROWTHWORKS, 71
Animal Science
LIONS CAPITAL CORP, 95MACKIE RESEARCH CAPITAL CORPORATION, 97
MARS INVESTMENT ACCELERATOR FUND, 102MMV CAPITAL PARTNERS, 107
Applications Software & Services
NSBI VENTURE CAPITAL Nova Scotia Business Inc., 116
OMERS VENTURES, 119ONTARIO CAPITAL GROWTH CORPORATION, 122
Automotive
TANDEM EXPANSION FUND, 142TERALYS CAPITAL, 148
Aviation
WELLINGTON FINANCIAL, 160YALETOWN VENTURE PARTNERS, 168
Biopharmaceuticals CTI LIFE SCIENCES FUND, 45 Cloud Computing Commercialization Biotechnology
DYNEX CAPITAL CORPORATION, 51FCC VENTURES Farm Credit Canada, 60
Communications
BDC VENTURE CAPITAL Business Development Bank of Canada, 14
CIBC CAPITAL PARTNERS, 37DISCOVERY CAPITAL CORPORATION, 49
Broadband
JEFFERSON PARTNERS, 87KILMER CAPITAL PARTNERS, 92
Portfolio Companies Index
Official Journal of the European Communitiesadapting to technical progress for the 27th time Council Directive 67/548/EEC on theapproximation of laws, regulations and administrative provisions relating to the classification,packaging and labelling of dangerous substances(*)THE COMMISSION OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the EuropeanThe texts in Annexes I a
Fakta schizofreni 1. Psykossjukdomar I Sverige insjuknar mellan 1 500 och 2 000 personer varje år i psykos varav schizofreni är den vanligaste formen. En psykos kan definieras som ett tillstånd där en persons verklighetsuppfattning är förändrad med symtom som hallucinationer, förföljelsemani, svårigheter att tänka och bristande sjukdomsinsikt. Det är oklart vad som orsak